News & Updates

Show Multimedia Only

Demographic-based LVH thresholds improves HCM diagnosis

25 Feb 2025

An individual’s age, sex, and body size can affect the normal heart maximum wall thickness (MWT), and using a fixed left ventricular hypertrophy (LVH) threshold of ≥15 mm tends to skew the diagnosis of LVH in patients with hypertrophic cardiomyopathy (HCM) and people with comorbidities, reveals a study.

Demographic-based LVH thresholds improves HCM diagnosis

25 Feb 2025

Purified oat protein may induce immune activation in coeliac disease

25 Feb 2025

Intake of gluten-free oats appears to trigger acute dose-dependent immune and symptom responses, although they rarely lead to prolonged symptoms or intestinal damage, according to a study.

Purified oat protein may induce immune activation in coeliac disease

25 Feb 2025

Antenatal corticosteroid reduces neonatal morbidities in late preterm twins

25 Feb 2025 by

Antenatal corticosteroid betamethasone administration significantly reduces the risk of neonatal respiratory morbidity in women with twin pregnancies at risk of late preterm delivery, according to the ACTWIN* trial presented at SMFM 2025.

Antenatal corticosteroid reduces neonatal morbidities in late preterm twins

25 Feb 2025

CKD management in primary care: Why use SGLT2i?

25 Feb 2025 by

Primary care physicians, as patients’ first point of contact, play an important role in early detection and timely management of chronic kidney disease (CKD). Sodium-glucose cotransporter-2 inhibitors’ (SGLT2i) positive data in CKD trials have established their role as first-line therapy recommended by international and Hong Kong guidelines. At an industry-sponsored symposium organized by the Hong Kong College of Family Physicians, experts reviewed empagliflozin’s benefits in broad populations of CKD patients, and discussed how its early initiation may slow CKD progression and delay dialysis. Case reports were presented to illustrate real-world benefits of empagliflozin among patients managed in primary care in Hong Kong.

CKD management in primary care: Why use SGLT2i?

25 Feb 2025

$Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids$

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

24 Feb 2025

Proton pump inhibitors (PPIs) are linked to heightened risk of fractures among older adults with autoimmune rheumatic and gastrointestinal diseases, especially when PPIs are used in conjunction with glucocorticoids, according to a study.

Older adults with autoimmune diseases at increased fracture risk when using PPIs, steroids

24 Feb 2025

Metabolic health also factors in obesity-related cancer risk in postmenopausal women

24 Feb 2025 by

New research suggests that metabolic health, not just weight, plays a significant role in the development of obesity-related cancers in postmenopausal women.

Metabolic health also factors in obesity-related cancer risk in postmenopausal women

24 Feb 2025

Plant-based meat may lower cholesterol, weight in adults

24 Feb 2025

Replacing meat with plant-based meat alternatives (PBMAs) results in a reduction in total cholesterol (TC), low-density lipoprotein (LDL)-cholesterol, and body weight in adults without cardiovascular diseases, a study has shown.

Plant-based meat may lower cholesterol, weight in adults

24 Feb 2025

Aspirin use lowers risk of common GI cancers

24 Feb 2025 by

Taking aspirin contributes to a reduced risk of several gastrointestinal (GI) malignancies, such as colorectal cancer (CRC), liver cancer, stomach cancer, and pancreatic cancer, as shown by the results of a 20-year study presented at ASCO GI 2025. However, no association is seen with most non-GI cancers.